Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Enei
Observed names:
Y. Enei,
YUKI ENEI
Institutions:
Jikei University School of Medicine,
Atsugi City Hospital
Observed institutions:
Jikei University School of Medicine,
Jikei University Kashiwa hospital,
Atsugi City Hospital,
The Jikei University West Medical Center
ORCID:
0009-0006-1124-2322
Observed ORCID:
0009-0006-1124-2322
OpenAlex ID:
A5043335982
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study
2024
·
Fumihiko Urabe
, Yu Imai
, et al.
·
Japanese Journal of Clinical Oncology
·
24
PDF
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer
2021
·
Takafumi Yanagisawa
, Takahiro Kimura
, et al.
·
The Prostate
·
23
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
2025
·
Takafumi Yanagisawa
, Akihiro Matsukawa
, et al.
·
Prostate Cancer and Prostatic Diseases
·
14
PDF
Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy
2023
·
Takafumi Yanagisawa
, Kenichi Hata
, et al.
·
The Prostate
·
13
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis
2022
·
Takafumi Yanagisawa
, Takahiro Kimura
, et al.
·
World Journal of Urology
·
13
PDF
Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer
2022
·
Takafumi Yanagisawa
, Takahiro Kimura
, et al.
·
The Prostate
·
11
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma
2021
·
Wataru Fukuokaya
, Takahiro Kimura
, et al.
·
Cancer Immunology Immunotherapy
·
11
Clear identification of the rare solitary external iliac lymph node metastasis of testicular cancer by using indocyanine green fluorescence guidance
2021
·
Yuki Enei
, Fumihiko Urabe
, et al.
·
IJU Case Reports
·
6
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma
2021
·
Wataru Fukuokaya
, Takahiro Kimura
, et al.
·
Targeted Oncology
·
6
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab
2020
·
Wataru Fukuokaya
, Takahiro Kimura
, et al.
·
British Journal of Urology
·
6
Comparison of diagnostic performance between manual diagnosis following PROMISE V2 and aPROMISE utilizing Ga/F-PSMA PET/CT
2025
·
Yuki Enei
, Takafumi Yanagisawa
, et al.
·
Annals of Nuclear Medicine
·
5
Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort study
2024
·
on behalf of JIKEI-YAYOI Collaborative Group
, Ryotaro Yamaguchi
, et al.
·
Translational Andrology and Urology
·
3
Effect of Adequate Local Radiation Dose on Oncological Outcomes in Localized Prostate Cancer Patients Treated With Low-dose-rate Brachytherapy
2023
·
YUKI ENEI
, FUMIHIKO URABE
, et al.
·
Anticancer Research
·
3
PDF
Pagetoid spread of urothelial carcinoma controlled without resection
2022
·
Shutaro Yamamoto
, Tatsuya Shimomura
, et al.
·
IJU Case Reports
·
3
PDF
No survival benefit found after extended treatment with docetaxel for patients with castration‐resistant prostate cancer
2019
·
Masatoshi Tanaka
, Takahiro Kimura
, et al.
·
The Prostate
·
2
Bleeding Events Associated With Continuing Antithrombotic Therapy During Transrectal Ultrasound‐Guided Prostate Biopsy: A Propensity Score‐Matched Analysis
2026
·
Kenichi Hata
, Yuma Goto
, et al.
·
International Journal of Urology
·
1
Real-world outcomes of prostate-specific membrane antigen-targeted radioligand therapy in Japanese patients with metastatic castration-resistant prostate cancer
2025
·
Yuki Enei
, Takafumi Yanagisawa
, et al.
·
Japanese Journal of Clinical Oncology
·
1
PDF
Novel “double‐pulling” technique for neobladder‐urethral anastomosis in laparoscopic radical cystectomy
2020
·
Takafumi Yanagisawa
, Jun Miki
, et al.
·
International Journal of Urology
·
1
Pd51-11 Utility of Salvage Percutaneous Cryoablation for Locally Recurrence Rcc After Primary Cryoablation
2019
·
Takafumi Yanagisawa*
, Jun Miki
, et al.
·
The Journal of Urology
·
1
The pathological diagnostic convenience and accuracy of en-bloc TUR specimen: Analysis of 10 pathologists
2019
·
T. Yanagiswawa
, T. Yorozu
, et al.
·
European Urology Supplements
·
1
Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation
2026
·
Hiroki Sai
, Hidetoshi Kuruma
, et al.
·
Clinical Genitourinary Cancer
Real‐World Outcomes of Combination Therapy With Radium‐223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration‐Resistant Prostate Cancer
2026
·
Kenichi Hata
, Yuma Goto
, et al.
·
Advances in Urology
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomy
2025
·
Kenichi Hata
, Yuma Goto
, et al.
·
BJUI Compass
PDF
Upfront Docetaxel With Androgen Deprivation Therapy in Males With High-volume Metastatic Castration-sensitive Prostate Cancer: Results of a Single-institution Series
2024
·
Kenichi Hata
, Masaki Hashimoto
, et al.
·
The Japanese Journal of Urology
PDF
Show more works
View as search
Works count:
24
Citation count:
148
H-index:
7
I10-index:
7
Year
Topic
Type